Neonatal jaundice from breast milk inhibitor Save
ICD-10 code: P59.3
Chapter: Certain conditions originating in the perinatal period
Understanding Neonatal Jaundice from Breast Milk Inhibitor
Neonatal jaundice is a common condition that affects many newborn babies, occurring in up to 60% of all infants. It is a condition that causes the skin and the whites of the eyes to turn yellowish in color due to the accumulation of bilirubin, a yellow pigment found in the blood.
One of the most common causes of neonatal jaundice is the presence of a breast milk inhibitor. This inhibitor is a substance that is found in breast milk that can interfere with the breakdown of bilirubin in the baby's liver, leading to an accumulation of the pigment in the bloodstream.
It is important to note that not all babies who are exposed to breast milk inhibitors develop jaundice. The condition is more common in premature babies and those who have difficulty breastfeeding. Additionally, certain medical conditions such as blood type incompatibility between mother and baby can also increase the risk of neonatal jaundice.
Symptoms of Neonatal Jaundice
The most common symptom of neonatal jaundice is yellowing of the skin and whites of the eyes. In some cases, the yellowing may spread to other parts of the body. Other symptoms of neonatal jaundice include:
- Poor feeding or sucking
- Lethargy or lack of energy
- Dark urine
- Light-colored stools
- Fever or other signs of infection
Treatment of Neonatal Jaundice
In most cases, neonatal jaundice resolves on its own within a few weeks. However, if the condition is severe or if the baby is at risk of complications, treatment may be necessary. The most common treatment for neonatal jaundice is phototherapy, which involves exposing the baby's skin to special lights that help to break down the bilirubin in the bloodstream.
In some cases, exchange transfusion may be necessary. This involves replacing the baby's blood with blood from a donor that does not contain high levels of bilirubin. This procedure is reserved for severe cases of neonatal jaundice and is only performed in a hospital setting.
Conclusion
Neonatal jaundice from breast milk inhibitor is a common condition that affects many newborn babies. While most cases of neonatal jaundice resolve on their own, it is important to seek medical attention if your baby develops symptoms of the condition. With prompt diagnosis and treatment, most babies with neonatal jaundice can make a full recovery.